HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.
Meeting News

Toxicity, costs must be considered when using chemotherapy-immunotherapy combinations for lung cancer

March 25, 2019
Two faculty members at HemOnc Today New York debated whether immunotherapy alone or in combination with chemotherapy is the ideal treatment approach…
Meeting News

Experts debate CAR T-cell therapy vs. transplant for relapsed diffuse large B-cell lymphoma

March 23, 2019
NEW YORK — Chimeric antigen receptor T-cell therapy confers better outcomes than autologous stem cell transplant to some patients with relapsed…

CAR T-cell therapy changing the landscape of lymphoma treatment

March 23, 2019
NEW YORK — Chimeric antigen receptor T cell therapies could be the breakthrough hematologists have sought to effectively treat certain patients…
Meeting News

Future ‘very bright’ in acute myeloid leukemia

March 23, 2019
NEW YORK — Treatment options for acute myeloid leukemia have evolved rapidly, but the expanded armamentarium has created a new set of…
Meeting News

First-line treatment for metastatic renal cell carcinoma evolving, but biomarkers still lacking

March 22, 2019
NEW YORK — First-line treatment of patients with metastatic renal cell carcinoma has evolved considerably in the past 18 months with FDA…
Meeting News

Rising PSA contributes to lack of clarity in nonmetastatic prostate cancer

March 22, 2019
NEW YORK — PSA is an “imperfect biomarker” that should inform prostate cancer treatment but not dictate it, according to a…

Molecular therapy for lung cancer has not evolved quickly enough

March 22, 2019
Molecular therapy for the treatment of lung cancer has not evolved enough to adequately extend survival of patients, according to a presenter at…

Immunotherapy likely to become standard for recurrent/metastatic head and neck cancers

March 22, 2019
The standard treatment for patients with recurrent or metastatic head and neck cancers is expected to change from chemotherapy to immunotherapy based…
Meeting News

Cisplatin superior to cetuximab for locally advanced head and neck cancer

March 22, 2019
NEW YORK — Cisplatin appears to be superior to cetuximab for patients with locally advanced head and neck cancer regardless of HPV status…
Meeting News

Genetic testing can detect melanoma earlier, but tailored approach is required

March 21, 2019
Genetic testing can help increase early detection of melanoma among patients and their family members, according to a presenter at HemOnc Today New…